RQM+ Welcomes Two New C-Suite Members

RQM+ has appointed Ronnie Mahofski and Kevin Rowland both to executive vice president and general manager. Mahofski will lead the company’s Consulting Services and Fern.ai business units, while Rowland will head Jordi Labs.
 
“These strategic appointments reflect RQM+’s dedication to returning to the fundamentals that have made us pioneers in the industry. We are confident that Ronnie and Kevin’s leadership will further our mission of bringing innovative, safe, and effective medical technology to the patients who need it,” RQM+ CEO John Potthoff said.
 
In his expanded role, Mahofski will oversee the regulatory and quality consulting services and the corresponding business development team, as well as tech enablement efforts with Fern.ai. He joined RQM+ in 2015, excelling in key business development roles and serving as head of Mergers and Acquisitions.
 
Rowland has been an integral part of Jordi Labs for nearly 15 years, serving as team leader for the GCMS and LCMS groups, as well as laboratory manager and R&D director. His expertise includes the interpretation of high-resolution accurate mass MS data for identifying non-target, unknown compounds. In his new role, Rowland will provide service to Jordi Labs’ customers and ensure product safety for patients in need.
 
RQM+ is a medtech service provider offering consulting, clinical trial, lab, and reimbursement services, as well as technology solutions to support the entire product lifecycle. 
 
Jordi Labs, an RQM+ company, provides contract analytical services to some of the world’s leading consumer products, polymers, pharmaceutical, and medical device manufacturers. Its team of PhD analytical chemists specialize in chemical identification. One of the core competencies is extractables and leachables testing.
 
Fern.ai, an RQM+ company, is a life sciences-focused artificial intelligence/machine learning platform to empower clients to seamlessly manage compliance requirements and efficiently navigating the dynamic regulatory landscape. Fern.ai is the only platform  designed to enhance the entire medtech lifecycle to deliver quality, speed to market, and compliance from concept to commercialization.